Pain Relieving
Menthol
Safetec Of America, Inc.
Human Otc Drug
NDC 61010-4403Pain Relieving also known as Menthol is a human otc drug labeled by 'Safetec Of America, Inc.'. National Drug Code (NDC) number for Pain Relieving is 61010-4403. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Pain Relieving drug includes Menthol - 4 g/100g . The currest status of Pain Relieving drug is Active.
Drug Information:
| Drug NDC: | 61010-4403 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Pain Relieving |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Menthol |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Safetec Of America, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Gel |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | MENTHOL - 4 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Nov, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 08 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Safetec of America, Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 415974
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | L7T10EIP3A
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 61010-4403-1 | 113.4 g in 1 TUBE (61010-4403-1) | 01 Nov, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose cooling pain relief
Product Elements:
Pain relieving menthol menthol menthol aloe vera leaf arctium lappa root arnica montana frankincense fd&c blue no. 1 calendula officinalis flower green tea leaf camphor (natural) carbomer homopolymer type c (allyl pentaerythritol crosslinked) glycerin ilex paraguariensis leaf isopropyl alcohol melissa officinalis leaf water silicon dioxide fd&c yellow no. 5 .alpha.-tocopherol acetate triethylamine
Indications and Usage:
Use temporary relief from minor aches and pains of sore muscles and joints associated with: arthritis, backache, strains sprains.
Warnings:
Warnings for external use only. flammable: keep away from excessive heat or open flame. ask a doctor before use if you have: sensitive skin. when using this product: avoid contact with eyes or mucous membranes do not apply to wounds or damaged skin do not use with other ointments, creams, sprays or liniments do not apply to irritated skin or if excessive irritation develops do not bandage wash hands after use with cool water do not use with heating pad or device stop use and ask a doctor if: condition worsens symptoms last more than 7 days or clear up and occur again within a few days. if pregnant or breast feeding : ask a health professional before use.
When Using:
When using this product: avoid contact with eyes or mucous membranes do not apply to wounds or damaged skin do not use with other ointments, creams, sprays or liniments do not apply to irritated skin or if excessive irritation develops do not bandage wash hands after use with cool water do not use with heating pad or device
Dosage and Administration:
Directions adults and children 2 years of age and older : rub a thin film over affected areas not more than 4 times daily; massage not necessary children under 2 years of age: consult a physician
Stop Use:
Stop use and ask a doctor if: condition worsens symptoms last more than 7 days or clear up and occur again within a few days.
Package Label Principal Display Panel:
Principal display panel â 4 oz pain relieving gel safetec ® pain relieving gel for minor aches & pains of muscles & joints net wt. 4 oz. (113.4g) reorder no. 58002 manufactured for: safetec of america, inc. buffalo, ny 14215 i 1-800-456-7077 made in india kd/739 principal display panel â 4 oz pain relieving gel